Quo vadis Endocrine.

摘要

This is my first Editorial as Editor-in-Chief of Endocrine and, first of all, I would like to welcome all the old and new readers of the journal to what I hope will be, for most of them, a common house for staying in touch with the latest advancements in basic and clinical endocrine research.Previous Editor-in-Chief and founder of the journal, Dr. Michael Conn, has done a wonderful job of achieving a strong reputation for Endocrine in the scientific community. When Springer, the new and very well-known publisher of the journal, first contacted me about the opportunity to become the new Editor-in-Chief, my feelings were mixed. I felt honored and pleased but, at the same time, conscious of accepting a big challenge. Now the decision has been made, and you probably do not want to hear more about private things, such as my family being a little nervous about my having extra work on nights and weekends. Instead, I guess you are much more interested in knowing what we already did for the journal and along what lines we intend to move toward the future of Endocrine.